MAPT and Alzheimer disease: Alzheimer’s disease (AD) is a chronic neurodegenerative disease characterised histopathologically by abnormal aggregates of amyloid-β (forming extracellular plaques) and microtubule-associated protein tau (forming intracellular neurofibrillary tangles) in the brain, affecting memory, motor function and cognition [1].